Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 119,706 | 14,128 | 39,655 | -110,938 | -81,911 |
| Depreciation Amortization | 15,302 | 6,546 | 2,281 | 6,485 | 4,114 |
| Income taxes - deferred | -11,791 | -40,021 | -40,021 | -2,460 | N/A |
| Accounts receivable | -5,540 | -3,508 | -203 | -7,959 | -4,676 |
| Accounts payable and accrued liabilities | -1,172 | -3,417 | -2,106 | 20,604 | 13,764 |
| Other Working Capital | -280 | -7,985 | -2,535 | 12,600 | 7,681 |
| Other Operating Activity | -114,062 | 35,681 | -3,665 | 35,818 | 24,273 |
| Operating Cash Flow | $2,163 | $1,424 | $-6,594 | $-45,850 | $-36,755 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -89,816 | 282 | 282 | -3,749 | -7,990 |
| PPE Investments | 148,376 | 3,282 | 3,286 | -663 | -581 |
| Net Acquisitions | -33,430 | -33,430 | -33,430 | -29,150 | -29,150 |
| Purchase Of Investment | N/A | N/A | N/A | -400 | -400 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 2,190 |
| Purchase Sale Intangibles | -5,271 | -2,497 | -948 | -3,301 | -3,302 |
| Other Investing Activity | -5,271 | -2,497 | -948 | -3,301 | -3,302 |
| Investing Cash Flow | $19,859 | $-32,363 | $-30,810 | $-37,263 | $-39,233 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 85,290 | 85,290 |
| Debt Repayment | N/A | N/A | N/A | -31,283 | -31,283 |
| Common Stock Issued | 159,063 | 152,709 | 150,131 | 48,398 | 45,172 |
| Common Stock Repurchased | N/A | N/A | N/A | -2,257 | -2,257 |
| Other Financing Activity | -58,693 | -12,228 | -10,756 | -4,828 | -1,069 |
| Financing Cash Flow | $100,370 | $140,481 | $139,375 | $95,320 | $95,853 |
| Beginning Cash Position | 18,204 | 18,204 | 18,204 | 5,997 | 5,997 |
| End Cash Position | 140,596 | 127,746 | 120,175 | 18,204 | 25,862 |
| Net Cash Flow | $122,392 | $109,542 | $101,971 | $12,207 | $19,865 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,163 | 1,424 | -6,594 | -45,850 | -36,755 |
| Capital Expenditure | -35 | -29 | -25 | -663 | -581 |
| Free Cash Flow | 2,128 | 1,395 | -6,619 | -46,513 | -37,336 |